These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9541388)

  • 21. HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state.
    Hornak V; Okur A; Rizzo RC; Simmerling C
    J Am Chem Soc; 2006 Mar; 128(9):2812-3. PubMed ID: 16506755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.
    Dusková J; Dohnálek J; Skálová T; Petroková H; Vondrácková E; Hradílek M; Konvalinka J; Soucek M; Brynda J; Fábry M; Sedlácek J; Hasek J
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):489-97. PubMed ID: 16627941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of water molecules in protein binding sites.
    Barillari C; Taylor J; Viner R; Essex JW
    J Am Chem Soc; 2007 Mar; 129(9):2577-87. PubMed ID: 17288418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulations of ligand-induced flap closing in HIV-1 protease approach X-ray resolution: establishing the role of bound water in the flap closing mechanism.
    Singh G; Senapati S
    Biochemistry; 2008 Oct; 47(40):10657-64. PubMed ID: 18785756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction.
    Pillai B; Kannan KK; Bhat SV; Hosur MV
    Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):594-6. PubMed ID: 14993705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.
    Perryman AL; Lin JH; McCammon JA
    Biopolymers; 2006 Jun; 82(3):272-84. PubMed ID: 16508951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
    Kurt N; Scott WR; Schiffer CA; Haliloglu T
    Proteins; 2003 May; 51(3):409-22. PubMed ID: 12696052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of HIV-1-PR inhibitors that do not create resistance: blocking the folding of single monomers.
    Broglia RA; Tiana G; Sutto L; Provasi D; Simona F
    Protein Sci; 2005 Oct; 14(10):2668-81. PubMed ID: 16195553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computation of binding free energy with molecular dynamics and grand canonical Monte Carlo simulations.
    Deng Y; Roux B
    J Chem Phys; 2008 Mar; 128(11):115103. PubMed ID: 18361618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting drug-resistant mutations of HIV protease.
    Ishikita H; Warshel A
    Angew Chem Int Ed Engl; 2008; 47(4):697-700. PubMed ID: 18058968
    [No Abstract]   [Full Text] [Related]  

  • 31. Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy.
    Yamazaki T; Hinck AP; Wang YX; Nicholson LK; Torchia DA; Wingfield P; Stahl SJ; Kaufman JD; Chang CH; Domaille PJ; Lam PY
    Protein Sci; 1996 Mar; 5(3):495-506. PubMed ID: 8868486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
    Meagher KL; Carlson HA
    J Am Chem Soc; 2004 Oct; 126(41):13276-81. PubMed ID: 15479081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
    Sadiq SK; Wan S; Coveney PV
    Biochemistry; 2007 Dec; 46(51):14865-77. PubMed ID: 18052195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D; Liu MS; Ji B; Hwang K; Huang Y
    J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex.
    Brynda J; Rezácová P; Fábry M; Horejsí M; Stouracová R; Soucek M; Hradílek M; Konvalinka J; Sedlácek J
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1943-8. PubMed ID: 15502300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of solvation by a generalized Born model and a self-consistent charge-density functional theory-based tight-binding method.
    Xie L; Liu H
    J Comput Chem; 2002 Nov; 23(15):1404-15. PubMed ID: 12370943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E; Samudrala R
    Antivir Ther; 2005; 10(1):157-66. PubMed ID: 15751773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of proximal His93 in nitric oxide binding to metmyoglobin. Application of continuum solvation in Monte Carlo protein simulations.
    Keserü GM; Menyhárd DK
    Biochemistry; 1999 May; 38(20):6614-22. PubMed ID: 10350480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
    Perez MA; Fernandes PA; Ramos MJ
    J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave-accelerated synthesis of P1'-extended HIV-1 protease inhibitors encompassing a tertiary alcohol in the transition-state mimicking scaffold.
    Ekegren JK; Ginman N; Johansson A; Wallberg H; Larhed M; Samuelsson B; Unge T; Hallberg A
    J Med Chem; 2006 Mar; 49(5):1828-32. PubMed ID: 16509598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.